Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharma IncfiledCriticalIncyte Pharma Inc
Priority claimed from PCT/US1996/004788external-prioritypatent/WO1996032485A1/en
Publication of MXPA97007852ApublicationCriticalpatent/MXPA97007852A/en
Publication of MX9707852ApublicationCriticalpatent/MX9707852A/en
The present invention provides nucleotide and amino acid sequences that identify and encode a novel phospholipase C homolog (plch and PLCH). The present invention also provides for antisense molecules to the plch nucleotide sequences, expression vectors for the production of purified PLCH, antibodies capable of binding specifically to PLCH, hybridization probes or oligonucleotides for detecting excess PLCH-encoding nucleotide sequences, genetically engineered host cells for the expression of PLCH, diagnostic tests for activated, inflamed, diseased, and hydroxyurea-resistant cells and/or tissues based on PLCH-encoding nucleotide sequences or antibodies specific for PLCH.
MX9707852A1996-04-101996-04-10Phospholipase c homolog.
MX9707852A
(en)